English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Regeneron Pharmaceuticals
Press release submission
| Jan 2, 2021
REGENERON: Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen
Press release submission
| Jul 5, 2020
Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients
Carol Ostrow
| Sep 23, 2017
Study shows Dupixent reduces symptoms of atopic dermatitis
Ruth de Jauregui
| May 7, 2017
Survey finds majority of rheumatoid arthritis patients living in pain
Ruth de Jauregui
| Apr 2, 2017
FDA approves Dupixent for atopic dermatitis
Trending
+
Community
Patient Daily
| Sep 24, 2025
Trump administration announces new measures against rising autism rates
+
Pharmaceuticals
Patient Daily
| Sep 25, 2025
NIH awards Baylor College of Medicine $15 million for rare diseases consortia
Patient Daily
| Sep 30, 2025
USC Keck graduates Brian Lee and Melody Glenn reflect physician presence in Phoenix area
+
Pharmaceuticals
Patient Daily
| Sep 24, 2025
American Lung Association launches campaign on lung cancer screening and biomarker testing
